|Name||CMIC HOLDINGS Co., Ltd.|
|Address||Hamamatsucho Building, 1-1-1,
|URL||CMIC HOLDINGS Co., Ltd. https://en.cmicgroup.com/
CMIC CMO Co., Ltd. http://www.cmic-cmo.com/e/index.html
Business Development Dept.
The CMIC Group has developed a business model that comprehensively supports the value chain of pharmaceutical companies, from pharmaceutical research and development to manufacturing and sales, and provides a one-stop service as a Pharmaceutical Value Creator (PVC).
Among them, CMIC CMO has six manufacturing bases in Japan and overseas and Pharmaceutical Development Center in Japan, and covers almost all solid, semi-solid, and injectable preparations for drug products manufacturing including the setting of specifications and test methods, product formulation studies, investigational product manufacturing, packaging design, stability testing for J-NDA, regulatory registration support, and the commercial production.
In addition, we provide a stable supply of high-quality products through an efficient production system, so that we can respond flexibly to a wide range of customer needs. Also, through alliances with leading overseas CMOs, we can offer contract manufacturing services in Europe, the United States, ASEAN regions.
[CMIC group’s CDMO business]
PHARMACEUTICAL DEVELOPMENT CENTER: Pre-formulation, formulation, manufacturing of investigational products and scale-up development.
SHIZUOKA PLANT: Manufacturing of solid preparations.
NISHINE PLANT: Manufacturing of solid preparations (including granulation by using organic solvent).
ASHIKAGA PLANT: Manufacturing of solid preparations and injectable preparations.
TOYAMA PLANT: Manufacturing of semi-solid preparations (including semi-solid preparations containing high levels of alcohol).
CMIC CMO KOREA: Manufacturing of semi-solid preparations.
CMIC CMO, USA: Manufacturing of solid preparations, manufacturing of investigational products for clinical studies in USA, and pharmaceutical development of solid preparations.